Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in connecticut, 2008-2009

American Journal of Public Health

Volumn 103, Issue 1, 2013, Pages 156-163

  Niccolai, Linda M ^a   Julian, Pamela J ^a   Bilinski, Alyssa ^a   Mehta, Niti R ^a   Meek, James I ^a   Zelterman, Daniel ^a   Hadler, James L ^a   Sosa, Lynn ^a,b  

^a YALE UNIVERSITY   (United States)

^b Yale School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER GRADING; CAUCASIAN; ETHNIC GROUP; ETHNOLOGY; FEMALE; GEOGRAPHY; HEALTH CARE DISPARITY; HISPANIC; HUMAN; NEGRO; PATHOLOGY; POVERTY; PRECANCER; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONNECTICUT; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEOGRAPHY; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; NEOPLASM GRADING; POVERTY; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872560702     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300447     Document Type: Review

References (54)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6-10. (Pubitemid 38258322)
2. Dunne EF, Unger ER, Sternbreg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819. (Pubitemid 46333946)
3. Manhart LE, Holmes KK, Koutsky LA, et al. Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis. 2006;33(8): 502-508. (Pubitemid 44126894)
4. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218-226. (Pubitemid 36152435)
5. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19. (Pubitemid 29406813)
6. Muñoz N, Bosch FX, de Sanjosé W, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6): 518-527.
7. Cervical cancer. NIH Consensus Statement. 1996; 14(1):1-38.
8. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101(5):1051-1057. (Pubitemid 39100440)
9. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2 pt 1):360-370. (Pubitemid 46197429)
10. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the US, 1998-2003. Cancer. 2008; 113(10 suppl):2855-2864.
11. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Updated November 10, 2010. Available at: http://seer.cancer.gov/csr/1975-2008. Accessed March 28, 2012.
12. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Painting a truer picture of US socioeconomic and racial/ethnic health inequalitites: the Public Health Disparities Geocoding Project. Am J Public Health. 2005;95(2):312-323. (Pubitemid 40179832)
13. McCarthy AM, Dumanovsky T, Visvanathan K, Kahn AR, Schymura MJ. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control. 2010;21(10):1645-1655.
14. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197(4):340-345. (Pubitemid 47464166)
15. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Moody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004;128(11):1224-1229. (Pubitemid 39441643)
16. Insinga RP, Glass AG, Rush BB. The health care costs of cervical human papillomavirus-related disease. Am J Obstet Gynecol. 2004;191(1):114-120. (Pubitemid 39077963)
17. Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG. 2002;109(4):364-368. (Pubitemid 37338011)
18. Lawson HW, Lee NC, Thames SF, Henson R, Miller DS. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol. 1998;92(5):745-752. (Pubitemid 28487668)
19. Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191(1):105-113. (Pubitemid 39077962)
20. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915-1927.
21. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301-314.
22. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):626-629.
23. Muñoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325-339.
24. Saraiya M, McCaig LF, Ekwueme DU. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States. Am J Manag Care. 2010;16(6):e137-e144.
25. Kohli M, Ferko N, Martin A, et al. Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer. 2007;96(1):143-150. (Pubitemid 46094653)
26. Huh WK. Impact of quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle vaccine on the incidence of abnormal Pap tests and cervical procedures. Gynecol Oncol. 2008;108(3 suppl 1):S10.
27. Connecticut Department of Public Health. Reportable diseases and laboratory reportable significant findings: changes for 2008. Conn Epidemiologist. 2008; 28(1):1-3.
28. Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471-482. (Pubitemid 34976986)
29. Bureau of the Census, US Department of Commerce. Frequently asked questions. Available at: https://ask. census.gov. Accessed September 9, 2010.
30. US Census Bureau. 2000 Census of Population and Housing, Summary File 3: Technical Documentation, 2002. Available at: http://www.census.gov/prod/cen2000/ doc/sf3.pdf. Accessed March 29, 2012.
31. Federal Financial Institutions Examination Council. Available at: http://www.ffiec.gov/geocode. Accessed March 26, 2012.
32. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of areabased socioeconomic measures-the Public Health Disparities Geocoding Project. Am J Public Health. 2003; 93(10):1655-1671. (Pubitemid 38477631)
33. US Census Bureau. 2000. Poverty. Available at: http://www.census.gov/ hhes/www/poverty/data/census/2000/index.html. Accessed March 26, 2012.
34. Wheeler CM. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am. 2008;35(4): 519-536, vii.
35. Khan MJ, Partridge EE, Wang SS, Schiffman M. Socioeconomic status and risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer. 2005;104(1):61-70. (Pubitemid 40847753)
36. Howell LP, Gurusinghe S, Tabnak F, Sciortino S. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing. Cancer Detect Prev. 2009; 32(5-6):372-379.
37. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540. (Pubitemid 36297783)
38. Nelson DE, Bolen J, Marcus S, Wells HE, Meissner H. Cancer screening estimates for US metropolitan areas. Am J Prev Med. 2003;24(4):301-309. (Pubitemid 36506687)
39. Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. Black women. Cancer. 2006;106(3):664-669. (Pubitemid 43157631)
40. Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008;66(2):260-275. (Pubitemid 350236484)
41. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006; 60(3):202-207. (Pubitemid 43288624)
42. Benjamins MR, Kirby JB, Bond Huie SA. County characteristics and racial and ethnic disparities in the use of preventive services. Prev Med. 2004;39(4):704-712. (Pubitemid 39194732)
43. Burton DC, Flannery B, Bennett NM, et al. Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health. 2010;100(10):1904-1911. doi:.
44. Advisory Committee on Immunization Practices. Vaccine for Children Program. Vaccines to prevent human papillomavirus. Resolution No. 010/09-1. Available at: http://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/ 1009hpv-508.pdf. Accessed July 22, 2010.
45. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32): 1018-1023.
46. Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L. Overcoming barriers to HPV vaccination in high-risk populations in the US. Gynecol Oncol. 2010;117(3):486-490.
47. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010;7(3):279-286.
48. Neubrand TPL, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila). 2009;48(9):966-969.
49. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127(1):77-84.
50. Yousey-Hindes KM, Hadler JL. Neighborhood socioeconomic status and influenza hospitalizations in children: New Haven County, Connecticut, 2003-2010. Am J Public Health. 2011;101(9):1785-1789.
51. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. (Pubitemid 47371147)
52. US Census Bureau. Connecticut quick facts. Available at: http://quickfacts.census.gov/qdf/states/09000.html. Accessed January 30, 2011.
53. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Data. Atlanta, GA: Centers for Disease Control and Prevention and National Cancer Institute; 2010. Available at: http://www.cdc.gov/uscs. Accessed March 28, 2012.
54. Insinga RP, Liaw K-L, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1611-1622.